Chun-Ho Lee

Chun-Ho Lee

Auto-generated profile, based on publicly available information

Chun-Ho Lee

School of Public Health National Defense Medical Center Taipei Taiwan, R.O.C.

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

18 December 2009 in Journal of Signal Processing Systems
Verified
Journal Article
Closed access
PDF file
Hsientsai WuHsientsai Wu
Hsientsai Wu
CLChun-Ho Lee
Chun-Ho Lee
ALAn-Bang Liu
An-Bang Liu

15 July 2025 in Journal of the American Heart Association
Verified
Journal Article
Open access
WLWei-Ting Liu
Wei-Ting Liu
CLChin Lin
Chin Lin
CLChiao-Chin Lee
Chiao-Chin Lee
CCChiao-Hsiang Chang
Chiao-Hsiang Chang
Wen-Hui FangWen-Hui Fang
Wen-Hui Fang
Chin-Sheng LinChin-Sheng Lin
Chin-Sheng Lin
Background: Atrial fibrillation (AF) is often underdiagnosed and undertreated by noncardiologists. This study evaluated whether artificial intelligence–enabled ECG (AI‐ECG) alerts could improve AF diagnosis and non–vitamin K antagonist oral anticoagulant prescriptions by noncardiologists. Methods: In this open‐label, cluster randomized controlled trial (NCT05127460) at 2 hospitals in Taiwan, noncardiologists were randomized to an intervention group (AI‐ECG alerts) or control group (usual care). Alerts were sent to physicians when AI‐ECG identified AF in emergency or hospitalized patients at risk of stroke (CHA₂DS₂‐VASc ≥1 for men, ≥2 for women), excluding those with prior AF or oral anticoagulant use. Primary end points included a non–vitamin K antagonist oral anticoagulant prescription within 90 days after discharge, new AF diagnosis, echocardiogram arrangements, and cardiologist visits. Secondary end points were ischemic stroke, cardiovascular death, and all‐cause death. Results: A total of 8857 and 8960 patients were treated by 120 and 113 noncardiologists in the intervention and control groups, respectively; 275 and 245 patients had AI‐detected AF. The non–vitamin K antagonist oral anticoagulant prescription rate was significantly higher in the intervention group (23.3% versus 12.0%; hazard ratio [HR], 1.85 [95% CI, 1.11–3.07]). The intervention group also had a higher rate of AF diagnosis (HR, 1.40 [95% CI, 1.03–1.90]). No significant differences were observed in echocardiogram arrangements, cardiologist visits, or the rates of ischemic stroke, cardiovascular death, and all‐cause death. Conclusions: An AI‐ECG alert for AF identification promoted non–vitamin K antagonist oral anticoagulant prescriptions among noncardiologists, thus reducing the disparity in AF care quality between cardiologists and noncardiologists. Registration: URL: https://clinicaltrials.gov/ ; Unique identifier: NCT05127460.

20 August 2025 in European Heart Journal - Digital Health
Verified
Journal Article
Open access
CCChiao-Hsiang Chang
Chiao-Hsiang Chang
Chin-Sheng LinChin-Sheng Lin
Chin-Sheng Lin
CLChun-Ho Lee
Chun-Ho Lee
CHIN LINCHIN LIN
CHIN LIN
CLChiao-Chin Lee
Chiao-Chin Lee
DTDung-Jang Tsai
Dung-Jang Tsai
Aims: Early detection of the need for coronary revascularization and timely intervention may reduce fatal events, but limited screening tools often leads to underdiagnosis. The aim of this study is to use a deep learning model (DLM) that utilizes electrocardiography (ECG) and the eXtreme Gradient Boosting (XGBoost) model to predict risk of coronary revascularization in the general population. Methods and results: This study included patients with at least one ECG per patient. The development set comprised 113 451 patients for training a DLM. After excluding patients with elevated troponin I levels and those without follow-up records, the internal validation set consisted of 66 680 patients. The external validation was conducted using data from a community hospital. XGBoost predicted events based on demographic data and ECG features. The primary endpoint was coronary revascularization within 1 year. Model performance was evaluated using the C-index. The DLM stratified patients by risk of coronary revascularization within 1 year. The study included 51% males with a mean age of 53 years, 10% with diabetes, and a revascularization rate of 2.6%. High-risk patients had a hazard ratio of 9.77 (95% CI: 7.63–12.51) compared with low-risk patients. The C-index was 0.825 (95% CI: 0.81–0.84). Combining demographic and AI-ECG data, XGBoost achieved a C-index of 0.884 (95% CI: 0.87–0.89). Comparative C-index analysis revealed significantly different discriminative performance between models (P = 1.110223e−15). Conclusions: The DLM demonstrates ECG's potential as a screening tool for coronary revascularization, enabling opportunistic detection and prompting further evaluation of high-risk patients.